Published date: 21 July 2020

Last edited date: 21 July 2020

This notice was replaced on 21 July 2020

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Opportunity (published 22 July 2020, last edited 25 November 2020)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

East Midlands, East of England, London, North East, North West, Scotland, South East, South West, Wales, West Midlands, Yorkshire and the Humber, Northern Ireland, Channel Islands

Value of contract

£0

Procurement reference

CF-0002800D0O000000rwimUAA4

Published date

21 July 2020

Closing date

3 August 2020

Contract start date

17 August 2020

Contract end date

30 April 2021

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

This is an accelerated procedure.

Justification

The Covid-19 outbreak has given rise to an urgent need for the supply of azithromycin capsules or tablets because the Authority needs to be in a position to treat the population as required. This does not give the Authority sufficient time to comply with the standard open procedure time scales for this procurement. The authority considers this to be a state of urgency which it has duly substantiated.\r

Accordingly, the authority is using the\r

accelerated time limits permitted under the Public Contract Regulations 2015\r

(Regulation 27(5) for the open procedure)\r

in respect of this procurement.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

This procurement exercise may result in\r
one or more contracts for the provision of\r
azithromycin capsules or tablets. The\r
approximate volumes required by the\r
Authority is up to 5 million doses (for the\r
purposes of this volume requirement a\r
dose is a 250mg dose of Azithromycin in\r
either capsule or tablet form). Deliveries\r
will be required no later than 31 December 2020, with an option to extend the contract for up to an additional 4 months.

More information

Previous notice about this procurement

Contract for the supply of azithromycin

  • Opportunity
  • Published 21 July 2020, last edited 21 July 2020

Links

About the buyer

Contact name

Lynne Nichols

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
GB

Email

lynne.nichols@dhsc.gov.uk